Dr Francesco Michelangeli

Dr Francesco Michelangeli

School of Biosciences
Honorary Senior Lecturer

Francesco (Frank) Michelangeli was until recently a senior lecturer and Head of Biochemistry programmes within the School of Biosciences at the University of Birmingham. He is now Professor of Biochemistry at the University of Chester. Frank gained his PhD from the University of Southampton, under the supervision of Professor A.G. Lee. He was subsequently awarded a NATO fellowship to undertake research into Ca2+ homeostasis mechanisms at the University of Padua, Italy, under the guidance of Professor Tullio Pozzan. His main research interests are in membrane biochemistry and Ca2+ transport proteins in particular. To date, Frank has published over 100 papers in these fields and has been on the editorial boards of several journals including The Biochemical Journal, Bioscience Reports and The Biochemical Society Transactions. Frank was the honorary membership secretary and a trustee of the Biochemical Society, where he was actively involved in promoting the Society and improving engagement with its members. Recently Frank was also elected to serve on the FEBS & Biochemical Society Education committees.

Frank teaches many aspects of biochemistry / biomedical sciences to undergraduates studying for degrees in the biosciences and biomedical sciences. In addition he also teaches on the MSc programme in Toxicology. His lecture topics cover a variety of subjects including metabolism, regulation of enzymes, signal transduction, membranes and transport, pharmacology, immunology and the molecular basis of disease. His particular teaching interests are in the development of specific laboratory / scientific skills and he has devised numerous undergraduate practical classes in enzymology, lipid analysis, immunology, pharmacology and cell signalling.


B.Sc (Hons) Biochemistry University of Lancaster

Ph.D Biochemistry University of Southampton

Fellow of the Society of Biology (FSB)


Full research description:

Biochemical characterisation of ER Ca2+ Channels & Pumps

Currently, my work has been focusing on links between aberrations in Ca2+ signalling pathways (caused by diseases or toxic insults) and induction of cell death. This work has used a variety of cells derived from neuronal, cardiovascular and testicular sources. My more recent work has involved investigating the molecular basis of toxicity of environmental pollutants and how they can affect male fertility and neuronal function. As an extension to this work, in collaboration with others I am also investigating the role of Ca2+ transporters in sperm viability and motility. Another current area of research is an investigation of the Golgi-specific Ca2+ pump (SPCA) and its modulation by novel regulatory proteins.

Other areas of interest include:

  • Kinetics, pharmacology and regulation of intracellular Ca2+ channels such as the InsP3 receptor and Ryanodine receptor.
  • Kinetics, pharmacology and regulation of Ca2+ ATPases.
  • Drug-membrane interactions.

Development of fluorescence-based assays.

Other activities

I regularly referee grant applications in the area of calcium homeostasis for possible funding by the research councils and medical charities.

I have served as an editorial advisor for the Biochemical Journal (1992-1995) and as an editorial board member from 1995-2002. I am currently on the editorial boards of Bioscience Reports, Biochemical Society Transactions and The Open Journal of Enzyme Inhibition.

I was on the executive committee and council of the Biochemical Society and  its Honorary Membership Secretary until end 2013.

I am a Pharmacology adviser / expert to the Pakistan High Commission for Education, were I have assessed promotions to chairs in several universities in Pakistan.


A Plethora of interacting organellar Ca2+ stores.
F. Michelangeli, O.A. Ogunbayo & L.L. Wootton (2005)
Current Opinions in Cell Biology 17, 135-140

Complex [Ca2+]i signals in human spermatozoa depend upon a Ca2+ store regulated by secretory pathway Ca2+-ATPase (SPCA1) Ca2+ pumps
C. Harper, L. Wootton, F. Michelangeli, L. Lefievre, C. Barratt, S. Publicover (2005)
J. Cell Science 118, 1673-1685

Calcium signalling in human spermatozoa: a specialized ‘toolkit’ of channels, transporters and stores.
C. Jimenez-Gonzalez, F. Michelangeli, C.V. Harper, C.L.R. Barratt & S.J. Publicover (2006)
Human Reproduction Update 12; 253-267

The effects of the phenylalanine 256 to valine mutation on the sensitivity of SERCA Ca2+ pump isoforms: 1, 2 & 3 to thapsigargin and other inhibitors
L.L. Wootton & F. Michelangeli (2006)
Biol. Chem. 281; 6970-6976

Understanding the physiology of pre-fertilization events in the human spermatozoa- a necessary prerequisite to developing rational therapy
S.J. Conner, L. Lefievre, J. Kirkman-Brown, F. Michelangeli, C. Jimenez-Gonzalez, G.S.M. Macchado-Oliveirea, K.L. Pixton, I.A. Brewis, C.L.R. Barrat & S.J. Publicover (2007)
Soc. Reprod. Fertil. Suppl. 63; 237-255

The interactions of the brominated flame retardant: Tetrabromobisphenol A with phospholipid membranes
O.A. Ogunbayo, K.T. Jensen, F. Michelangeli (2007)
Biochimica et Biophysica Acta 1768; 1559-1566

The brominated flame retardant, tetrabromobisphenol A, inhibits SERCA Ca2+ pumps and sensitizes the Ryanodine receptor
O.A. Ogunbayo, H. Ho Tin Wu, F. Michelangeli (2007)
Proceedings Physiol. Soc. Life Sciences; PC 270

The effects of tetrabromobisphenol-A, a brominated flame retardant, on Ca2+ signalling and cell viability in Sertoli cells
P.F. Lai, O.A. Ogunbayo, T.J. Connolly, F. Michelangeli (2007)
Proceedings Physiol. Soc. Life sciences; PC271

The widely utilized brominated flame retardant, tetrabromobisphenol A (TBBPA) is a potent inhibitor of the SERCA Ca2+ pump.
O.A. Ogunbayo & F. Michelangeli (2007).
Biochemical Journal. 408; 407- 415

The brominated flame retardant, Tetrabromobisphenol-A (TBBPA), induces cell death in cultured Testicular TM4 Sertoli cells via a mechanism involving Ca2+ mobilization: TBBPA can affect both SERCA Ca2+ pumps and Ryanodine receptor Ca2+ channels.
O.A. Ogunbayo, P.F. Lai, T.J. Connolly & F. Michelangeli (2008)
Toxicology In-Vitro 22; 943-952

Endocrine disrupting alkylphenols: Structural requirements for their adverse effects on Ca2+ pumps, Ca2+ homeostasis & Sertoli TM4 cell viability.
F. Michelangeli, O.A. Ogunbayo, L.L. Wootton, P.F. Lai, F. Al-Mousa, R.M. Harris, R.H. Waring & C.J. Kirk. (2008)
Chemico-Biological Interactions 176; 220-226

Inhibition of the sarcoplasmic / endoplasmic reticulum Ca2+-ATPase (SERCA) by flavonoids: A quantitative structure-activity relationship study.
O.A. Ogunbayo, R.N. Harris, R.H. Waring, C.J. Kirk & F. Michelangeli (2008)
IUBMB-Life 60; 853-858

The commonly used Ryanodine receptor activator, 4-chloro-m-cresol (4CmC), is also an inhibitor of SERCA Ca2+ pumps.
F. Al-Mousa and F. Michelangeli (2009)
Pharmacological Reports   61; 838-842

Dual mechanism of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria.
D. Hermanson, S,N. Addo, A.A. Bajer, J.S. Marchant, S. Goutam, K. Das, B. Srinivasan, F. Al-Mousa, F. Michelangeli, D.D. Thomas, T.W. LeBien, C. Xing (2009)
Molecular Pharmacology  76; 667-678

Changes in expression and activity of the secretory pathway Ca2+ ATPase 1 (SPCA1) in A7r5 vascular smooth muscle cells, cultured at different glucose concentrations.
P. Lai and F. Michelangeli (2009)
Bioscience Reports  29;  397-404

Ca2+-stores in sperm: their identities and functions.
S. Costello, F. Michelangeli , K. Nash, L. Lefievre, C. Ford, J. Morris, G. Machado-Oliveira, J. Kirkman-Brown, S. Publicover. (2009)
Reproduction 138;  425-437

Alisol B is a novel inhibitor of the SERCA pump that induces autophagy, ER-stress and apoptosis
B.Y.K. Law, M. Wang, E. Ma, F. Al-Mousa, F. Michelangeli, A. Wong, M. Ng, K. To,  A.Y.F. Mok, S.K. Lam, F. Chen, C. Che, P. Chiu, B.C.B. Ko. (2010)
Mol Cancer Therapeutics  9;  718-730

A Diversity of SERCA Ca2+ pump Inhibitors
F. Michelangeli & J.M. East (2011)
Biochemical Society Transactions 39;  789-797

Recent advances in membrane biochemistry
J.M. East & F. Michelangeli (2011)
Biochemical Society Transactions 39; 703-709

Regucalcin (RGN/SMP30) alters agonist- and thapsigargin-induced cytosolic [Ca2+] transients in cells by increasing SERCA Ca2+ATPase levels
P. Lai & F. Michelangeli (2011)
FEBS Letts 585, 2291-2294

Some commonly used brominated flame retardants cause Ca2+-ATPase inhibition, , beta-amyloid peptide release and apoptosis in SH-SY5Y neuronal cells 
F. Al-Mousa & F. Michelangeli  (2012)
PLOS One   7; e33059,   1-8

Bis(2-hydroxy-3-tert-butyl-5-methyl-phenyl)-methane (bis-phenol) is a potent and selective inhibitor of the secretory pathway Ca2+ ATPase (SPCA1)
P. Lai & F. Michelangeli (2012)
Biochem. Biophys. Res. Comm.  424;  616-619

Ca2+ signalling through CatSper and Ca2+ stores generates functional diversity in human sperm behavior.
S. Costello, W. Alasari, J. Correia, S.K. Oxenham, L. Fernandes, J. Kirkman-Brown,
 F. Michelangeli, C. Barratt & S. Publicover
J. Biol Chem. (2013)   288;   6248-6258

Saikosaponin-d, a novel SERCA inhibitor induces autophagic cell death in apoptosis-defective cells.
VKW Wong, T Li, BYK Law, EDL Ma, NC Yip, F Michelangeli, CKM Law, MM Zhang,
KYC Lam, PL Chan, & L Liu
Cell Death & Disease (2013)    4; e720   doi 10.1038/cddis.2013.217

The sarcoplamsic-endoplasmic reticulum Ca2+-ATPase (SERCA) is the likely molecular target for the acute toxicity of the brominated flame retardant, hexabromocyclododecane (HBCD)
F. Al-Mousa & F. Michelangeli
Chemico-Biological Interactions (2014) 207; 1-6

Related flavonoids cause Cooperative inhibition of the the sarcoplasmic reticulum Ca2+ATPase by multimode mechanisms
O.A. Ogunbayo & F. Michelangeli
FEBS Journal   (2014)    (in press)